IRVINE, Calif. -- Advanced Sterilization Products (ASP) announces that its STERRAD® CYCLESURE® Biological Indicator readout time has improved from a 48-hour incubation time to only 24 hours. Now, STERRAD® System customers can safely record biological indicator results in 50 percent less time, speeding up instrument throughput in the sterilization department. The product name is also changing to STERRAD® CYCLESURE® 24 Biological Indicator to reflect this time-saving improvement.
ASP successfully re-engineered the product after receiving feedback from customers requesting a faster incubation period. A faster incubation period keeps sterilization departments moving efficiently as well as limiting the need to purchase duplicate instrument inventories, which is frequently required when waiting for the results of a 48-hour or more biological indicator readout.
“ASP has been providing healthcare organizations with STERRAD® System technology and supplies for almost two decades,” says Karen Borg, worldwide vice president of marketing for ASP. “We are committed to continuous product innovation and are passionate about designing and marketing infection prevention solutions like the STERRAD® CYCLESURE® 24 Biological Indicator that not only meet our customers’ needs, but often exceed them.”
The STERRAD® CYCLESURE® 24 Biological Indicator can be used with all of ASP’s market-leading, low-temperature hydrogen peroxide gas plasma STERRAD® Systems: the STERRAD® 100NX™ System, STERRAD® NX™ System, STERRAD® 100S System, STERRAD® 200 System, as well as the STERRAD® 50 System. The STERRAD® CYCLESURE® 24 Biological Indicator is only validated for use in STERRAD® Systems.
For information about STERRAD® System products, ASP or ASP’s line of infection prevention solutions, visit http://www.sterrad.com or call 1-888-STERRAD.
Source: Advanced Sterilization Products (ASP)
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.